Listing 1 - 10 of 96 | << page >> |
Sort by
|
Choose an application
Volker H. Schmitt untersucht die Gewebereaktion auf fünf Barrierematerialien histologisch, immunhistochemisch und ultrastrukturell. Der Autor kann zeigen, dass der ultrastrukturelle Befund mit dem makroskopischen Ergebnis korreliert, die effektivste Barriere zeigte das größte Ausmaß an Remesothelialisierung. Eine bislang als negativ interpretierte Inflammation ging mit geringerer Adhäsionsbildung einher. Es gab keine Korrelation zwischen dem Vorhandensein CD68-positiver Makrophagen und der Gewebereaktion. Solche Untersuchungen der Biokompatibilität und Oberflächenmorphologie sind essentiell für die Weiterentwicklung materialbasierter Ansätze, weg von rein physikalischen Barrieren hin zu funktionalen Biomaterialien im Sinne des Tissue Engineering. Diese Untersuchung ist praxisnah und weiterführend, da durch serosale Schädigung entstehende peritoneale Adhäsionen eine häufige Komplikation in der Abdominalchirurgie darstellen. Der Inhalt Serosale Wundheilung, Pathogenese peritonealer Adhäsionen, präventive Strategien Materialbedingte Gewebereaktion Rolle CD68-positiver Makrophagen Ultrastrukturelle Materialevaluation Die Zielgruppen Dozierende und Studierende sowie Praktiker der Pathologie, Chirurgie, Gynäkologie und Materialwissenschaften Der Autor Volker H. Schmitt war wissenschaftlicher Mitarbeiter am Institut für Pathologie der Universitätsmedizin Mainz. Derzeit ist er Arzt in Weiterbildung am Zentrum für Kardiologie der Johannes Gutenberg-Universität Mainz mit Forschungstätigkeit in vaskulärer Biologie und Epidemiologie.
Pathology. --- Biomaterials. --- Surgery.
Choose an application
Biomedical materials. --- Biocompatible materials --- Biomaterials --- Medical materials --- Medicine --- Biomedical engineering --- Materials --- Biocompatibility --- Prosthesis --- Bioartificial materials --- Hemocompatible materials --- Biomaterials (Biomedical materials)
Choose an application
Biomedical materials --- Biocompatible materials --- Biomaterials --- Medical materials --- Medicine --- Biomedical engineering --- Materials --- Biocompatibility --- Prosthesis --- Bioartificial materials --- Hemocompatible materials --- Biomaterials (Biomedical materials)
Choose an application
Wound Healing Biomaterials: Volume Two, Functional Biomaterials discusses the types of wounds associated with trauma, illness, or surgery that can sometimes be extremely complex and difficult to heal. Consequently, there is a prominent drive for scientists and clinicians to find methods to heal wounds opening up a new area of research in biomaterials and the ways they can be applied to the challenges associated with wound care. Much research is now concerned with new therapies, regeneration methods, and the use of biomaterials that can assist in wound healing and alter healing responses. This book provides readers with a thorough review of the functional biomaterials used for wound healing, with chapters discussing the fundamentals of wound healing biomaterials, films for wound healing applications, polymer-based dressing for wound healing applications, and functional dressings for wound care. Includes more systematic and comprehensive coverage on the topic of wound care Provides thorough coverage of all specific therapies and biomaterials for wound healing Contains clear layout and organization that is carefully arranged with clear titles and comprehensive section headings Details specific sections on the fundamentals of wound healing biomaterials, films for wound healing applications, polymer-based dressing for wound healing applications, and more.
Biomedical materials. --- Wound healing. --- Biocompatible materials --- Biomaterials --- Medical materials --- Medicine --- Biomedical engineering --- Materials --- Biocompatibility --- Prosthesis --- Bioartificial materials --- Hemocompatible materials --- Biomaterials (Biomedical materials)
Choose an application
Biomedical materials. --- Lasers --- Industrial applications. --- Biocompatible materials --- Biomaterials --- Medical materials --- Medicine --- Biomedical engineering --- Materials --- Biocompatibility --- Prosthesis --- Bioartificial materials --- Hemocompatible materials --- Biomaterials (Biomedical materials)
Choose an application
Biomedical materials. --- Tissue engineering. --- Biomedical engineering --- Regenerative medicine --- Tissue culture --- Biocompatible materials --- Biomaterials --- Medical materials --- Medicine --- Materials --- Biocompatibility --- Prosthesis --- Bioartificial materials --- Hemocompatible materials --- Biomaterials (Biomedical materials)
Choose an application
The proceedings of the workshop "Advanced Materials for Technical and Medical Purpose" (AMTMP-2016 was organized by Institute of High Technology Physics and held on February 15-17, 2016 in Tomsk Polytechnic University, Tomsk, Russia) covers the research works and technologies aimed at the treatment of materials and deposition of coatings, design of new-generation composites, additive manufacturing of metallic and non-metallic articles, materials for biomedical application . The workshop was targeted at sharing of opinions and discussion the problems existing in the areas and ways of their solution. Additive technologies, materials, multiscale composites, coatings, nanotechnology, numerical simulation, discharge and plasma-beam technology, biomedicine materials science.
Materials science --- Materials science. --- Biomedical materials. --- Biocompatible materials --- Biomaterials --- Medical materials --- Medicine --- Biomedical engineering --- Materials --- Biocompatibility --- Prosthesis --- Material science --- Physical sciences --- Bioartificial materials --- Hemocompatible materials --- Biomaterials (Biomedical materials)
Choose an application
In times of declining fossil stocks, science and industry have to find alternative resources for the production of fuels and chemicals. This book presents techniques for the utilization of biomass and waste as raw materials for the production of platform molecules, biopolymers, bioplastics, and bioethanol. Latest research results as well as industrial application thereof are discussed.
Biomedical materials. --- Biocompatible materials --- Biomaterials --- Medical materials --- Medicine --- Biomedical engineering --- Materials --- Biocompatibility --- Prosthesis --- Bioartificial materials --- Hemocompatible materials --- Biomaterials (Biomedical materials) --- Bioethanol. --- Biomass. --- Bioplastics. --- Biopolymers. --- Foodwaste.
Choose an application
Tissue engineering is an innovative, multidisciplinary approach which combines (bio)materials, cells and growth factors with the aim to obtain neo-organogenesis to repair or replenish damaged tissues and organs. The generation of engineered tissues and organs (e. g. skin and bladder) has entered into the clinical practice in response to the chronic lack of organ donors. In particular, for the skeletal and cardiac muscles the translational potential of tissue engineering approaches has clearly been shown, even though the construction of this tissue lags behind others given the hierarchical, highly organized architecture of striated muscles. Cardiovascular disease is the leading cause of death in the developed world, where the yearly incidence of Acute MI (AMI) is approx 2 million cases in Europe. Recovery from AMI and reperfusion is still less than ideal. Stem cell therapy may represent a valid treatment. However, delivery of stem cells alone to infarcted myocardium provides no structural support while the myocardium heals, and the injected stem cells do not properly integrate into the myocardium because they are not subjected to the mechanical forces that are known to drive myocardial cellular physiology. On the other hand, there are many clinical cases where the loss of skeletal muscle due to a traumatic injury, an aggressive tumour or prolonged denervation may be cured by the regeneration of this tissue. In vivo, stem or progenitor cells are sheltered in a specialized microenvironment (niche), which regulates their survival, proliferation and differentiation. The goal of this research topic is to highlight the available knowledge on biomaterials and bioactive molecules or a combination of them, which can be used successfully to differentiate stem or progenitor cells into beating cardiomyocytes or organized skeletal muscle in vivo. Innovations compared to the on-going trials may be: 1) the successful delivery of stem cells using sutural scaffolds instead of intracoronary or intramuscular injections; 2) protocols to use a limited number of autologous or allogeneic stem cells; 3) methods to drive their differentiation by modifying the chemical-physical properties of scaffolds or biomaterials, incorporating small molecules (i.e. miRNA) or growth factors; 4) methods to tailor the scaffolds to the elastic properties of the muscle; 5) studies which suggest how to realize scaffolds that optimize tissue functional integration, through the combination of the most up-to-date manufacturing technologies and use of bio-polymers with customized degradation properties.
Angiogenesis --- Scaffold --- cardiac stem cells --- skeletal muscle --- Biomaterials --- Tissue Engineering --- satellite cells --- Angiogenesis --- Scaffold --- cardiac stem cells --- skeletal muscle --- Biomaterials --- Tissue Engineering --- satellite cells
Choose an application
Tissue engineering is an innovative, multidisciplinary approach which combines (bio)materials, cells and growth factors with the aim to obtain neo-organogenesis to repair or replenish damaged tissues and organs. The generation of engineered tissues and organs (e. g. skin and bladder) has entered into the clinical practice in response to the chronic lack of organ donors. In particular, for the skeletal and cardiac muscles the translational potential of tissue engineering approaches has clearly been shown, even though the construction of this tissue lags behind others given the hierarchical, highly organized architecture of striated muscles. Cardiovascular disease is the leading cause of death in the developed world, where the yearly incidence of Acute MI (AMI) is approx 2 million cases in Europe. Recovery from AMI and reperfusion is still less than ideal. Stem cell therapy may represent a valid treatment. However, delivery of stem cells alone to infarcted myocardium provides no structural support while the myocardium heals, and the injected stem cells do not properly integrate into the myocardium because they are not subjected to the mechanical forces that are known to drive myocardial cellular physiology. On the other hand, there are many clinical cases where the loss of skeletal muscle due to a traumatic injury, an aggressive tumour or prolonged denervation may be cured by the regeneration of this tissue. In vivo, stem or progenitor cells are sheltered in a specialized microenvironment (niche), which regulates their survival, proliferation and differentiation. The goal of this research topic is to highlight the available knowledge on biomaterials and bioactive molecules or a combination of them, which can be used successfully to differentiate stem or progenitor cells into beating cardiomyocytes or organized skeletal muscle in vivo. Innovations compared to the on-going trials may be: 1) the successful delivery of stem cells using sutural scaffolds instead of intracoronary or intramuscular injections; 2) protocols to use a limited number of autologous or allogeneic stem cells; 3) methods to drive their differentiation by modifying the chemical-physical properties of scaffolds or biomaterials, incorporating small molecules (i.e. miRNA) or growth factors; 4) methods to tailor the scaffolds to the elastic properties of the muscle; 5) studies which suggest how to realize scaffolds that optimize tissue functional integration, through the combination of the most up-to-date manufacturing technologies and use of bio-polymers with customized degradation properties.
Angiogenesis --- Scaffold --- cardiac stem cells --- skeletal muscle --- Biomaterials --- Tissue Engineering --- satellite cells
Listing 1 - 10 of 96 | << page >> |
Sort by
|